Suppr超能文献

一项针对健康志愿者进行的关于普瑞巴林认知和精神运动特征的双盲、安慰剂及阳性(阿普唑仑)内部对照研究。

A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers.

作者信息

Hindmarch Ian, Trick Leanne, Ridout Fran

机构信息

HPRU Medical Research Centre, School of Biomedical and Molecular Sciences, University of Surrey, Guildford, Surrey, GU2 7XP, UK.

出版信息

Psychopharmacology (Berl). 2005 Dec;183(2):133-43. doi: 10.1007/s00213-005-0172-7. Epub 2005 Nov 9.

Abstract

RATIONALE

Pregabalin potently and selectively binds to the alpha(2)-delta subunit of voltage-dependent calcium channels, reducing calcium influx and modulating release of downstream excitatory neurotransmitters, such as glutamate. Pregabalin has demonstrated robust efficacy for several disease states, but its neuropharmacology is still being elucidated.

OBJECTIVE

This study was conducted to evaluate the cognitive and psychomotor effects of oral pregabalin (150 mg t.i.d.) using alprazolam (1 mg t.i.d.) as a positive internal control and placebo.

METHODS

Twenty-four healthy volunteers were randomised to a double-blind, three-way crossover study. Each period consisted of 3-day double-blind treatment followed by 1 day of single-blind placebo. Psychometrics included tests of Choice Reaction Time (CRT), CNS arousal (Critical Flicker Fusion, CFF), vigilance (Rapid Visual Information Processing, RVIP), serial memory scanning (Sternberg Short-Term Memory Scanning Test, STM), divided attention (Compensatory Tracking Task, CTT), Brake Reaction Time (BRT) in an on-the-road vehicle, and subjective Line Analogue Rating Scales (LARS) for sedation.

RESULTS

Pregabalin showed no significant effects on the objective psychometrics-CRT, BRT, RVIP, STM-compared with placebo. Pregabalin produced a limited, significant decrement on CFF and CTT and a significant effect on the LARS. Pregabalin was associated with improvement relative to placebo in BRT. The positive control, alprazolam, produced significant impairment on all objective measures and significant impairment on the LARS, thus establishing the sensitivity of the test battery used in the study.

CONCLUSIONS

Pregabalin did not differ on most assessments from placebo, producing only minor, transient impairment on some objective cognitive and psychomotor measures, suggesting a relatively benign CNS side-effect profile.

摘要

理论依据

普瑞巴林能有效且选择性地结合电压依赖性钙通道的α₂δ亚基,减少钙内流并调节下游兴奋性神经递质(如谷氨酸)的释放。普瑞巴林已在多种疾病状态下显示出强大疗效,但其神经药理学仍在阐明之中。

目的

本研究旨在以阿普唑仑(每日三次,每次1毫克)作为阳性内部对照和安慰剂,评估口服普瑞巴林(每日三次,每次150毫克)对认知和精神运动的影响。

方法

24名健康志愿者被随机分配至一项双盲、三交叉研究。每个阶段包括3天的双盲治疗,随后是1天的单盲安慰剂治疗。心理测量包括选择反应时间(CRT)测试、中枢神经系统唤醒(临界闪烁融合,CFF)、警觉性(快速视觉信息处理,RVIP)、系列记忆扫描(斯特恩伯格短期记忆扫描测试,STM)、注意力分散(补偿跟踪任务,CTT)、道路行驶车辆中的制动反应时间(BRT),以及用于镇静的主观线性模拟评分量表(LARS)。

结果

与安慰剂相比,普瑞巴林对客观心理测量指标(CRT、BRT、RVIP、STM)无显著影响。普瑞巴林对CFF和CTT产生了有限的显著降低,对LARS有显著影响。与安慰剂相比,普瑞巴林使BRT有所改善。阳性对照药阿普唑仑对所有客观测量指标均产生显著损害,对LARS也有显著损害,从而证实了本研究中使用的测试组合的敏感性。

结论

在大多数评估中,普瑞巴林与安慰剂无差异,仅在一些客观认知和精神运动测量指标上产生轻微、短暂的损害,提示其具有相对良性的中枢神经系统副作用谱。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验